XGN
Exagen Inc. · Healthcare
President and CEO John Aballi sold $41K of Exagen Inc.
Sold$41,262
$3.61Price
11,430Shares
−2%Stake
What XGN did after the filing
- The stock from Wed, Feb 25 close, $3.80
- −18.7%
- S&P 500, same days
- −1.9%
Measured over 30 trading days, to the Apr 9 close.
Traded Tue, Feb 24. Filed Wed, Feb 25, 2:11 PM ET, during the session. Returns use the Feb 25 close and the Apr 9 close. Not investment advice.